Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
Novartis weighs sale of ophthalmology, respiratory units
Yahoo/Reuters
Wed, 11/16/22 - 12:05 pm
Novartis
Respiratory
ophthalmology
Novartis halts phase 1 cancer trial of CD73 antagonist over efficacy, but combo studies continue
Fierce Biotech
Wed, 11/16/22 - 10:40 am
Novartis
clinical trials
NZV930
Lantheus has three shots on goal to challenge Novartis
EP Vantage
Wed, 11/16/22 - 10:19 am
Lantheus Medical
Novartis
Point Biopharma
Pluvicto
Luthathera
In transition and tumult, Seagen names former Novartis oncology chief Epstein as new CEO
Fierce Pharma
Thu, 11/10/22 - 10:52 am
Seagen
Pharma CEOs
Novartis
Clay Siegall
David Epstein
Novartis cuts 275 jobs at Illinois site to consolidate Zolgensma manufacturing in North Carolina
Endpoints
Wed, 11/9/22 - 11:13 pm
Novartis
layoffs
gene therapy
Zolgensma
drug manufacturing
ASH preview – waiting for Editas
EP Vantage
Wed, 11/9/22 - 10:40 am
ASH 2022
sickle cell disease
Bluebird Bio
Sangamo BioSciences
Novartis
Editas Medicine
gene therapy
Vertex Pharmaceuticals
Sanofi
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Kyowa Kirin
Takeda
Eiger BioPharmaceuticals
AstraZeneca
Teva Pharmaceutical
Bavarian Nordic
Halozyme
Novartis
MannKind
drug development
What is Novartis without Sandoz? Vas Narasimhan is 'patient' as new company takes form
Endpoints
Tue, 10/25/22 - 11:13 pm
Novartis
Pharma CEOs
Vas Narasimhan
Novartis sales of Zolgensma gene therapy slow as market shifts
BioPharma Dive
Tue, 10/25/22 - 11:02 pm
Novartis
gene therapy
spinal muscular atrophy
SMA
Zolgensma
Novartis drops presbyopia drug acquired with Encore Vision
Pharmaphorum
Tue, 10/25/22 - 10:32 am
Novartis
presbyopia
UNR844
Encore VIsion
Novartis, eyeing $3B market, beats AstraZeneca blood disorder blockbusters in phase 3
Fierce Biotech
Mon, 10/24/22 - 11:17 pm
Novartis
iptacopan
clinical trials
Soliris
AstraZeneca
Ultomiris
Novartis’ oral drug iptacopan tops injectables in head-to-head PNH trial
Pharmaphorum
Mon, 10/24/22 - 10:47 am
Novartis
iptacopan
clinical trials
PNH
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
CP WIre
Thu, 10/20/22 - 12:21 pm
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
Thu, 10/20/22 - 12:27 pm
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
Gene therapy is saving lives, but key challenges to realize its full potential
MedCity News
Thu, 10/20/22 - 10:30 am
gene therapy
Novartis
Zolgensma
Roctavian
Zynteglo
Skysona
Novartis-partnered Orionis secures $55M to push cytokine program into clinic
Endpoints
Wed, 10/19/22 - 10:55 am
Orionis Biosciences
Novartis
funding
R&D
cytokines
Novartis, GSK and Sanofi Scale Back on Operations and Labor Forces Overseas - Updated
BioSpace
Mon, 10/17/22 - 10:46 am
Novartis
GSK
Sanofi
layoffs
Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal
Fierce Pharma
Fri, 10/14/22 - 10:40 am
Novartis
Gilenya
generics
Supreme Court
MS
multiple sclerosis
Novartis to lay off 400 at Dublin campus amid global restructuring
Fierce Pharma
Fri, 10/14/22 - 10:05 am
Novartis
Ireland
layoffs
restructuring
Novartis' Zolgensma Under Fire Again as Nature Retracts 2010 Paper
BioSpace
Wed, 10/12/22 - 11:45 pm
Novartis
Zolgensma
data manipulation
SMA
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »